CUVITRU sol inj 1 g/5ml flac 5 ml
7680659920015
CH-65992
J06BA01
08.09.
Reimbursement limitations:
CUVITRU
Pour le traitement des syndromes provoqués par l'absence d'anticorps. Prise en charge si la caisse …
1 / 3
google
Details
- Product number
- 6599201
- CPT
- -
- Packaging group
- 5
- Unit
- ml
- Composition
- Solvens (i.m.): immunoglobulinum humanum normale 200 mg, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Cuvitru 200 mg/ml, Injektionslösung
Injektionslösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLIM
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLIM
|
- | Substance | HNIDK |
|
SOLIM
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 87.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2017
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 65992
- Drug name
- Cuvitru, Injektionslösung zur subkutanen Anwendung
- Galenic form
- LSPA
- ATC Code
- J06BA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 14/10/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 08.09.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CUVITRU sol inj 1 g/5ml flac 5 ml
- Description (DE)
- CUVITRU Inj Lös 1 g/5ml Durchstf 5 ml
- Market launch
- 14/10/2016
- Narcotic (BTM)
- No